Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.19p
   
  • Change Today:
    -0.11p
  • 52 Week High: 5.60
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 843,322
  • Market Cap: £29.20m
  • Beta: 0.93

Latest ShareCast News

Director dealings: Poolbeg Pharma co-founder raise stake

By Iain Gilbert

Date: Wednesday 25 Jun 2025

(Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company.

Poolbeg Pharma extends cash runway after raising £4.87m

By Josh White

Date: Friday 23 May 2025

(Sharecast News) - Poolbeg Pharma announced on Friday that it has conditionally raised a total of £4.865m in gross proceeds through an upsized and oversubscribed BookBuild offer, placing, and subscription.

Poolbeg raises nearly £5m to progress clinical trials

By Benjamin Chiou

Date: Tuesday 20 May 2025

(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.

Poolbeg shares slide as Hookipa terminates takeo... 21-Feb-2025 ShareCast
Poolbeg Pharma says Gilead in favour of its comb... 10-Jan-2025 ShareCast
Poolbeg Pharma granted new US patent 20-Nov-2024 ShareCast
Poolbeg agrees 12-month option over potential Be... 30-Apr-2024 ShareCast
Poolbeg Pharma to be granted US patent 20-Mar-2024 ShareCast
Director dealings: Poolbeg Pharma co-founder ups... 19-Feb-2024 ShareCast
Poolbeg upbeat on research into potential drug m... 12-Feb-2024 ShareCast
Poolbeg makes promising progress with RSV progra... 20-Dec-2023 ShareCast
Poolbeg gets notice of a new Japan patent 20-Sep-2023 ShareCast
Poolbeg reports progress with oral vaccine devel... 22-Jun-2023 ShareCast
Poolbeg expands its focus molecule into oncology 16-Jan-2023 ShareCast
Poolbeg identifies new drug candidates with OneT... 21-Dec-2022 ShareCast
Poolbeg secures exclusive licence to possible ob... 14-Dec-2022 ShareCast
Poolbeg announces 'breakthrough' in AI drug targ... 08-Nov-2022 ShareCast
Poolbeg Pharma upbeat on US patent application p... 04-Oct-2022 ShareCast
Poolbeg inks exclusive deal for melioidosis vacc... 21-Sep-2022 ShareCast
Poolbeg granted European patent for antiviral no... 14-Apr-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 4.19p
Change Today -0.11p
% Change -2.62 %
52 Week High 5.60
52 Week Low 2.40
Volume 843,322
Shares Issued 697.20m
Market Cap £29.20m
Beta 0.93

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 06-Jan-2026

Time Volume / Share Price
13:34 9,649 @ 4.35p
13:04 13,500 @ 4.36p
12:11 2,607 @ 4.25p
11:57 39,563 @ 4.38p
11:53 100,000 @ 4.20p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page